Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 66 peer-reviewed journal articles Updated
Dermatology

Generalized Pustular Psoriasis (GPP): A Patient Guide

At a Glance

Generalized pustular psoriasis is a rare inflammatory disease that causes sudden widespread sterile pustules and can affect the whole body. Severe flares with fever, chills, exhaustion, or rapidly worsening skin need immediate medical attention and a specialist-led plan.

Generalized Pustular Psoriasis (GPP) is a rare and complex autoinflammatory disease that requires a different approach than common skin conditions. While it shares a name with plaque psoriasis, they are distinct illnesses. Both are immune-mediated, but in GPP, the body’s innate immune system becomes severely overactive, causing profound systemic inflammation [1]. It is characterized by the sudden appearance of sterile pustules—small, white, pus-filled bumps—that develop across wide areas of intensely red and inflamed skin [2]. Because these pustules are initially sterile, they are caused by internal inflammation rather than an infection, though the damaged skin can be incredibly painful and vulnerable to secondary infections later [3].

The underlying cause of GPP involves a biological “glitch” in the body’s internal alarm system, specifically a signaling pathway known as IL-36 [4]. In some people, this is linked to genetic variants (such as in the IL36RN gene) that prevent the body from “turning off” this inflammatory signal, leading to the rapid buildup of white blood cells in the skin [5][6]. However, a negative genetic test does not rule out GPP. This hyperactive response can be precipitated by various triggers, including sudden withdrawal from systemic corticosteroids, infections, pregnancy, medication changes, or physical and emotional stress [7].

GPP is unpredictable. Some people experience acute, severe flares separated by long periods of clear skin, while others have a more persistent form where mild symptoms are almost always present [8]. During a severe flare, the inflammation is not limited to the skin; it can affect the entire body, causing high fevers, chills, and extreme exhaustion [9]. Because these flares can occasionally mimic or lead to serious complications—like life-threatening organ dysfunction or secondary sepsis—they require immediate medical attention and often specialized hospital care [10][1].

Fortunately, breakthroughs have led to the development of targeted therapies designed specifically to block the IL-36 pathway [11]. These modern treatments, alongside conventional medications, allow doctors to create two-part plans: one to provide “rescue” during an active flare and another for long-term “maintenance” to keep future flares at bay [12][13]. Because GPP is so rare, your care must be managed by a dedicated team of specialists who can coordinate your treatment, provide a written emergency action plan, and support your overall well-being.

In this guide

6 chapters

01

Understanding Your Diagnosis: Generalized Pustular Psoriasis (GPP)

Learn what generalized pustular psoriasis (GPP) means, how relapsing and persistent patterns differ, and how GPPASI tracks severity and treatment response.

02

Symptoms, Triggers, and Emergency Warning Signs of GPP

Learn to recognize generalized pustular psoriasis (GPP) flare symptoms, common triggers, same-day care needs, and emergency warning signs such as sepsis.

03

The Biology of GPP and Look-Alike Conditions

Learn how generalized pustular psoriasis (GPP) involves IL-36 signaling and genetic changes, and distinguish it from AGEP, infections, and plaque psoriasis.

04

Diagnosis, Clinical Evaluation, and Blood Tests for GPP

Learn how generalized pustular psoriasis (GPP) is diagnosed, including skin biopsy findings, cultures, blood tests, and GPPASI severity scoring.

05

Standard of Care Treatment for GPP Flares and Maintenance

Learn how generalized pustular psoriasis flares are treated, including spesolimab, conventional medicines, maintenance therapy, and monitoring for safety.

06

Long-Term Management, Pregnancy, and Your Care Team

Learn how to manage generalized pustular psoriasis long term, including pregnancy planning, medication washout, routine monitoring, and flare anxiety support.

Common questions in this guide

How is generalized pustular psoriasis different from plaque psoriasis?
Generalized pustular psoriasis is a distinct disease from plaque psoriasis, even though they share the word psoriasis. GPP is an autoinflammatory illness that can cause sudden, widespread sterile pustules and severe inflammation throughout the body.
Are the pustules in GPP caused by an infection?
GPP pustules are initially sterile, meaning they are caused by internal immune inflammation rather than an infection. However, damaged skin can later develop a secondary infection, so worsening illness should be assessed promptly.
What can trigger a generalized pustular psoriasis flare?
Reported triggers include suddenly stopping systemic corticosteroids, infections, pregnancy, medication changes, and physical or emotional stress. Triggers vary from person to person, so keeping a symptom and trigger log can help your healthcare team identify patterns.
When does a GPP flare require urgent medical attention?
A severe flare may cause widespread inflamed skin, fever, chills, and extreme exhaustion, and it can sometimes lead to organ dysfunction or sepsis. Rapidly spreading pustules or severe whole-body symptoms require immediate medical attention and may require hospital care.
What treatments are available for generalized pustular psoriasis?
Treatment may include medicines that specifically block the IL-36 pathway as well as conventional medications. Your care team may create one plan to control an active flare and another long-term plan to reduce future flares.
Does a negative IL36RN genetic test rule out GPP?
No. IL36RN gene variants contribute to GPP in some people, but many people with GPP do not have an identifiable variant, so a negative genetic test does not rule out the disease. Genetic counseling can help explain whether testing is appropriate and how to interpret the result.
How can I prepare for another GPP flare?
Ask your healthcare team for a written emergency action plan that explains whom to contact and where to seek care if symptoms spread quickly. Tracking warning signs, symptoms, and possible triggers can also help your team adjust treatment and support faster decisions during a flare.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How would you describe my specific type of GPP—is it considered 'relapsing' or 'persistent'?
  2. 2.Do you have experience managing the IL-36 targeted therapies, and am I a candidate for them?
  3. 3.What is our immediate plan if I start to notice redness and pustules spreading rapidly over the weekend or after hours?
  4. 4.Is a referral for genetic counseling and testing for IL36RN appropriate to better understand the underlying cause of my condition?
  5. 5.Who are the other specialists, such as a rheumatologist or a high-risk OB/GYN, that you coordinate with for cases like mine?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Clinical Course and Characteristics of Generalized Pustular Psoriasis.

    Choon SE, Navarini AA, Pinter A

    American journal of clinical dermatology 2022; (23(Suppl 1)):21-29 doi:10.1007/s40257-021-00654-z.

    PMID: 35061227
  2. 2

    International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.

    Choon SE, van de Kerkhof P, Gudjonsson JE, et al.

    JAMA dermatology 2024; (160(7)):758-768 doi:10.1001/jamadermatol.2024.0915.

    PMID: 38691347
  3. 3

    Exploring the Clinical Presentation, Course, and Burden of Disease in Generalized Pustular Psoriasis [Podcast].

    Merola JF, Amin AZ

    Clinical, cosmetic and investigational dermatology 2024; (17()):539-545 doi:10.2147/CCID.S444221.

    PMID: 38482176
  4. 4

    The IL-36 cytokine family: From barrier immunity to therapeutic target in inflammatory diseases.

    Satoh TK, Mellett M, French LE

    Allergology international : official journal of the Japanese Society of Allergology 2026; (75(3)):366-379 doi:10.1016/j.alit.2026.01.006.

    PMID: 41723100
  5. 5

    IL36RN Mutations Affect Protein Expression and Function: A Basis for Genotype-Phenotype Correlation in Pustular Diseases.

    Tauber M, Bal E, Pei XY, et al.

    The Journal of investigative dermatology 2016; (136(9)):1811-1819 doi:10.1016/j.jid.2016.04.038.

    PMID: 27220475
  6. 6

    Mature IL-36γ Induces Stratum Corneum Exfoliation in Generalized Pustular Psoriasis by Suppressing Corneodesmosin.

    Sato E, Imayoshi H, Tsutsui Y, et al.

    The Journal of investigative dermatology 2024; (144(4)):764-773.e4 doi:10.1016/j.jid.2023.09.267.

    PMID: 37827276
  7. 7

    Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA.

    Shibata A, Sugiura K, Furuta Y, et al.

    Journal of autoimmunity 2017; (80()):28-38 doi:10.1016/j.jaut.2017.01.007.

    PMID: 28196704
  8. 8

    Generalized pustular psoriasis successfully treated with spesolimab: A case report.

    Brigenti N, Gisondi P, Bellinato F, Girolomoni G

    SAGE open medical case reports 2024; (12()):2050313X241235451 doi:10.1177/2050313X241235451.

    PMID: 38419797
  9. 9

    Exploring the Clinical Features, Immunopathogenesis and Approach to Diagnosis for Generalized Pustular Psoriasis [Podcast].

    Bhutani T, Hawkes JE

    Clinical, cosmetic and investigational dermatology 2023; (16()):1553-1558 doi:10.2147/CCID.S424073.

    PMID: 37351064
  10. 10

    Generalized pustular psoriasis: practical recommendations for Spanish primary care and emergency physicians.

    Rivera-Diaz R, Epelde F, Heras-Hitos JA, et al.

    Postgraduate medicine 2023; (135(8)):766-774 doi:10.1080/00325481.2023.2285730.

    PMID: 38019177
  11. 11

    Trial of Spesolimab for Generalized Pustular Psoriasis.

    Bachelez H, Choon SE, Marrakchi S, et al.

    The New England journal of medicine 2021; (385(26)):2431-2440 doi:10.1056/NEJMoa2111563.

    PMID: 34936739
  12. 12

    Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.

    Morita A, Strober B, Burden AD, et al.

    Lancet (London, England) 2023; (402(10412)):1541-1551 doi:10.1016/S0140-6736(23)01378-8.

    PMID: 37738999
  13. 13

    Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology.

    Puig L, Carrascosa JM, Rivera R, et al.

    Actas dermo-sifiliograficas 2026; (117(3)):104544 doi:10.1016/j.ad.2025.104544.

    PMID: 41371399

This information about generalized pustular psoriasis is for educational purposes only and does not constitute medical advice. Seek urgent medical care for a severe or rapidly worsening flare, and discuss treatment with your healthcare team.

Get notified when new evidence is published on Generalized pustular psoriasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.